Update: 14.03.2021
Last week: 9 week 2022 (28.02.2022 - 6.03.2022)
Last full month: Feb 2021
| Time period | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat.Vol, Change |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | |||||||||
| WoW | 3 391 | -5.6% | 62.0% | 3.6 | 1 772 957 | 6.0% | 87.4% | 3.1 | -11.1% |
| MoM | 11 577 | 16.9% | 55.7% | 4.2 | 5 204 099 | 19.8% | 82.7% | 2.8 | 8.1% |
| YTD | 27 657 | 8.0% | 55.3% | -3.7 | 12 627 180 | 38.5% | 82.6% | 1.1 | 15.2% |
| MAT | 119 655 | -20.8% | 54.8% | -6.8 | 49 120 507 | 5.2% | 80.6% | -0.7 | -11.0% |
| KAPSIKAM | |||||||||
| WoW | 24 360 | -11.6% | 3.1% | 0.1 | 10 554 039 | -10.4% | 2.9% | 0.2 | -14.5% |
| MoM | 184 740 | -6.2% | 3.7% | -0.2 | 75 707 986 | -6.3% | 3.8% | -0.3 | -1.2% |
| YTD | 232 925 | -7.5% | 3.6% | -0.3 | 96 463 116 | -9.0% | 3.6% | -1 | 0.3% |
| MAT | 1 046 347 | -20.1% | 3.3% | -0.4 | 429 379 627 | -12.6% | 3.5% | -0.5 | -10.5% |
| MILDRONATE | |||||||||
| WoW | 163 717 | -19.1% | 22.6% | -0.6 | 100 682 587 | -14.4% | 23.0% | 0.3 | -17.0% |
| MoM | 508 991 | 18.0% | 21.8% | 1 | 242 664 826 | 38.3% | 20.6% | 2.7 | 12.6% |
| YTD | 1 256 685 | 31.3% | 16.8% | 2.1 | 611 556 071 | 49.9% | 16.7% | 2.6 | 14.9% |
| MAT | 5 095 376 | 12.9% | 16.9% | 2.7 | 2 137 235 213 | 19.4% | 15.3% | 2.3 | -5.2% |
| SULFARGIN | |||||||||
| WoW | 4 082 | -0.1% | 0.8% | 0 | 2 074 371 | 1.5% | 1.0% | 0.1 | -0.1% |
| MoM | 14 059 | 2.0% | 1.0% | 0 | 6 756 585 | 0.2% | 1.3% | 0 | 2.0% |
| YTD | 34 489 | 8.7% | 0.9% | 0.1 | 16 874 572 | 13.6% | 1.2% | 0.1 | -3.4% |
| MAT | 166 916 | -19.0% | 0.8% | -0.1 | 81 785 021 | -7.6% | 1.2% | 0 | -9.4% |
| VIPROSAL | |||||||||
| WoW | 35 978 | -18.1% | 4.3% | -0.1 | 15 603 896 | -16.6% | 4.0% | 0 | -16.1% |
| MoM | 122 479 | 0.5% | 4.5% | 0.1 | 48 514 619 | 1.0% | 4.5% | 0 | -1.7% |
| YTD | 310 729 | 40.3% | 4.4% | 1.2 | 125 292 777 | 46.3% | 4.4% | 0.9 | 2.1% |
| MAT | 1 332 760 | -3.0% | 3.9% | 0.3 | 510 948 353 | 4.4% | 4.0% | 0.1 | -10.4% |
| Brand | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat.Vol, Change |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | 3 391 | -5.6% | 62.0% | 3.6 | 1 772 957 | 6.0% | 87.4% | 3.1 | -11.1% |
| KAPSIKAM | 24 360 | -11.6% | 3.1% | 0.1 | 10 554 039 | -10.4% | 2.9% | 0.2 | -14.5% |
| MILDRONATE | 163 717 | -19.1% | 22.6% | -0.6 | 100 682 587 | -14.4% | 23.0% | 0.3 | -17.0% |
| SULFARGIN | 4 082 | -0.1% | 0.8% | 0 | 2 074 371 | 1.5% | 1.0% | 0.1 | -0.1% |
| VIPROSAL | 35 978 | -18.1% | 4.3% | -0.1 | 15 603 896 | -16.6% | 4.0% | 0 | -16.1% |
| Brand | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat.Vol, Change |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | 11 577 | 16.9% | 55.7% | 4.2 | 5 204 099 | 19.8% | 82.7% | 2.8 | 8.1% |
| KAPSIKAM | 184 740 | -6.2% | 3.7% | -0.2 | 75 707 986 | -6.3% | 3.8% | -0.3 | -1.2% |
| MILDRONATE | 508 991 | 18.0% | 21.8% | 1 | 242 664 826 | 38.3% | 20.6% | 2.7 | 12.6% |
| SULFARGIN | 14 059 | 2.0% | 1.0% | 0 | 6 756 585 | 0.2% | 1.3% | 0 | 2.0% |
| VIPROSAL | 122 479 | 0.5% | 4.5% | 0.1 | 48 514 619 | 1.0% | 4.5% | 0 | -1.7% |
| Brand | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat.Vol, Change |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | 27 657 | 8.0% | 55.3% | -3.7 | 12 627 180 | 38.5% | 82.6% | 1.1 | 15.2% |
| KAPSIKAM | 232 925 | -7.5% | 3.6% | -0.3 | 96 463 116 | -9.0% | 3.6% | -1 | 0.3% |
| MILDRONATE | 1 256 685 | 31.3% | 16.8% | 2.1 | 611 556 071 | 49.9% | 16.7% | 2.6 | 14.9% |
| SULFARGIN | 34 489 | 8.7% | 0.9% | 0.1 | 16 874 572 | 13.6% | 1.2% | 0.1 | -3.4% |
| VIPROSAL | 310 729 | 40.3% | 4.4% | 1.2 | 125 292 777 | 46.3% | 4.4% | 0.9 | 2.1% |
| Brand | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat.Vol, Change |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | 119 655 | -20.8% | 54.8% | -6.8 | 49 120 507 | 5.2% | 80.6% | -0.7 | -11.0% |
| KAPSIKAM | 1 046 347 | -20.1% | 3.3% | -0.4 | 429 379 627 | -12.6% | 3.5% | -0.5 | -10.5% |
| MILDRONATE | 5 095 376 | 12.9% | 16.9% | 2.7 | 2 137 235 213 | 19.4% | 15.3% | 2.3 | -5.2% |
| SULFARGIN | 166 916 | -19.0% | 0.8% | -0.1 | 81 785 021 | -7.6% | 1.2% | 0 | -9.4% |
| VIPROSAL | 1 332 760 | -3.0% | 3.9% | 0.3 | 510 948 353 | 4.4% | 4.0% | 0.1 | -10.4% |
Abbreviations
WoW - Week Over Week Change = Sales of the last week / Sales of the previous week - 1
MoM - Month Over Month Change = Sales of the last full month / Sales of the previous full month - 1
YTD - Year to Date - a period of time beginning the first day of the current calendar year up to the current date
MAT - Moving Annual Total - a period, being any 12 month period ending on the last week
MS - Market Share
Data Sources:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs